Susana María Sicardi
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Susana María Sicardi.
Mutation Research\/genetic Toxicology | 1995
Susana María Sicardi; Estela Ferrato
Studies were undertaken to evaluate the ability of various quinoneimines to induce micronuclei in bone marrow cells as a measure of their genotoxicity. Accordingly, 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine (I), its 2-acetyl derivative (II) and 2-[(5-methyl-3-isoxazolyl)amino]-N-(5-methyl-3-isoxazolyl)-1 ,4- naphthoquinone-4-imine (III), as well as two of their precursors, 2-hydroxynaphthoquinone (NQ-2-OH) and 3,4-dimethyl-5-aminoisoxazole (DMAI) were given by intraperitoneal injection at 5, 50, 100 and 200 mg/Kg doses to S.J.L. Swiss mice with 24 h sampling time. Compounds I and II displayed highly significant differences at 50, 100 and 200 mg/kg doses (p < 0.01) and their mutagenic dose response curves correlated closely with an inverted U-shaped form whose interpretation is still the subject of controversy. NQ-2-OH only produced a significant increase in micronucleus frequency at 50 mg/kg, whereas no mutagenic activity was found for compound III and DMAI at the doses assayed. At 50 mg/kg the order of relative mutagenic potencies was I > II > NQ-2-OH. Mechanisms advanced to explain loss of drug activity at high doses include capture saturation, enzymatic induction during metabolism and participation of an independent defense system.
Información tecnológica | 2008
Javier H Gris; Martín A Dragonetti; Beatriz Fernández; Susana María Sicardi
Mutagenic potential of piroxicam (1), 2-aminopyridine (2), meloxicam (3) and 2-amino-5-methylthiazole (4) has been evaluated using in vivo micronucleus test. Four dose levels for each compound were used and bone marrow cells were examined 24 hours after the administration. In the case of the degradation product of piroxicam (2) only 0.1, 0.3, 1.0 and 5.0 mg/kg were evaluated, because at 50 mg/kg all animals died. The results show that doses applied do not induce a statistical significant increase of the frequency of micronucleated polychromatic erythrocytes. Aniline (5) has been used as positive mutagen reference, showing a positive response to the micronucleous induction at doses of 50mg/kg or superior while no induction occur with lower doses. The structural-mutagenic activity relationship between piroxicam and aniline could not been established.
Journal of Pharmaceutical Sciences | 1991
Susana María Sicardi; Jorge L. Martiarena; María T. Iglesias
Journal of Heterocyclic Chemistry | 1973
Susana María Sicardi; Samuel Lamdan; Carlos H. Caozza
Acta Farmacéutica Bonaerense | 1987
Susana María Sicardi; Jorge L. Martiarena; María T. Iglesias
Journal of Medicinal Chemistry | 1970
Samuel Lamdan; Carlos H. Gaozza; Susana María Sicardi; J. A. Izquierdo
Journal of Pharmaceutical Sciences | 1974
Susana María Sicardi; Samuel Lamdan; Carlos H. Gaozza
Journal of Heterocyclic Chemistry | 1999
Monica Dal Maso; Isabel A. Perillo; Celia B. Schapira; Susana Gorzalczany; María Cristina Dominga Acevedo; Susana María Sicardi
Acta Farmacéutica Bonaerense | 1998
Monica Dal Maso; Isabel A. Perillo; Celia B. Schapira; Susana Gorzalczany; María Cristina Dominga Acevedo; Susana María Sicardi
Acta farmacéutica bonaerense | 1994
Estela Ferrato; Margarita Briñón; Susana María Sicardi